- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Chlamydia Infection Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Chlamydia Infection Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Chlamydia Infection Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Abbott Laboratories
DiaSorin SpA
Bio Rad Laboratories
Thermo Fisher Scientific
Danaher Corporation
Novartis AG
Siemens AG
F Hoffmann-La Roche
BD Medical
BioMerieux
By Type:
Macrolides
Quinolones
Sulfonamides
Tetracycline
Aminopenicillins
Other
By End-User:
Hospital Pharmacies
Drugstores
Retail Pharmacies
Online Pharmacies
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Chlamydia Infection Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Macrolides from 2016 to 2027
-
1.3.2 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Quinolones from 2016 to 2027
-
1.3.3 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Sulfonamides from 2016 to 2027
-
1.3.4 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Tetracycline from 2016 to 2027
-
1.3.5 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Aminopenicillins from 2016 to 2027
-
1.3.6 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Drugstores from 2016 to 2027
-
1.4.3 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.4 China Chlamydia Infection Therapeutics Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Chlamydia Infection Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Chlamydia Infection Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Macrolides
-
3.4.2 Market Size and Growth Rate of Quinolones
-
3.4.3 Market Size and Growth Rate of Sulfonamides
-
3.4.4 Market Size and Growth Rate of Tetracycline
-
3.4.5 Market Size and Growth Rate of Aminopenicillins
-
3.4.6 Market Size and Growth Rate of Other
4 Segmentation of Chlamydia Infection Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Chlamydia Infection Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Chlamydia Infection Therapeutics in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Chlamydia Infection Therapeutics in Drugstores
-
4.4.3 Market Size and Growth Rate of Chlamydia Infection Therapeutics in Retail Pharmacies
-
4.4.4 Market Size and Growth Rate of Chlamydia Infection Therapeutics in Online Pharmacies
5 Market Analysis by Regions
-
5.1 China Chlamydia Infection Therapeutics Production Analysis by Regions
-
5.2 China Chlamydia Infection Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Chlamydia Infection Therapeutics Landscape Analysis
-
6.1 North China Chlamydia Infection Therapeutics Landscape Analysis by Major Types
-
6.2 North China Chlamydia Infection Therapeutics Landscape Analysis by Major End-Users
7 Central China Chlamydia Infection Therapeutics Landscape Analysis
-
7.1 Central China Chlamydia Infection Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Chlamydia Infection Therapeutics Landscape Analysis by Major End-Users
8 South China Chlamydia Infection Therapeutics Landscape Analysis
-
8.1 South China Chlamydia Infection Therapeutics Landscape Analysis by Major Types
-
8.2 South China Chlamydia Infection Therapeutics Landscape Analysis by Major End-Users
9 East China Chlamydia Infection Therapeutics Landscape Analysis
-
9.1 East China Chlamydia Infection Therapeutics Landscape Analysis by Major Types
-
9.2 East China Chlamydia Infection Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Chlamydia Infection Therapeutics Landscape Analysis
-
10.1 Northeast China Chlamydia Infection Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Chlamydia Infection Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Chlamydia Infection Therapeutics Landscape Analysis
-
11.1 Southwest China Chlamydia Infection Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Chlamydia Infection Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Chlamydia Infection Therapeutics Landscape Analysis
-
12.1 Northwest China Chlamydia Infection Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Chlamydia Infection Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Abbott Laboratories
-
13.1.1 Abbott Laboratories Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 DiaSorin SpA
-
13.2.1 DiaSorin SpA Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Bio Rad Laboratories
-
13.3.1 Bio Rad Laboratories Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Thermo Fisher Scientific
-
13.4.1 Thermo Fisher Scientific Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Danaher Corporation
-
13.5.1 Danaher Corporation Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Novartis AG
-
13.6.1 Novartis AG Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Siemens AG
-
13.7.1 Siemens AG Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 F Hoffmann-La Roche
-
13.8.1 F Hoffmann-La Roche Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 BD Medical
-
13.9.1 BD Medical Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 BioMerieux
-
13.10.1 BioMerieux Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Macrolides from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Quinolones from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Sulfonamides from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Tetracycline from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Aminopenicillins from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Drugstores from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Chlamydia Infection Therapeutics Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Chlamydia Infection Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Chlamydia Infection Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Chlamydia Infection Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Chlamydia Infection Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Chlamydia Infection Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Macrolides
-
Figure Market Size and Growth Rate of Quinolones
-
Figure Market Size and Growth Rate of Sulfonamides
-
Figure Market Size and Growth Rate of Tetracycline
-
Figure Market Size and Growth Rate of Aminopenicillins
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Chlamydia Infection Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Chlamydia Infection Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Drugstores
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Online Pharmacies
-
Table China Chlamydia Infection Therapeutics Production by Regions
-
Table China Chlamydia Infection Therapeutics Production Share by Regions
-
Figure China Chlamydia Infection Therapeutics Production Share by Regions in 2016
-
Figure China Chlamydia Infection Therapeutics Production Share by Regions in 2021
-
Figure China Chlamydia Infection Therapeutics Production Share by Regions in 2027
-
Table China Chlamydia Infection Therapeutics Consumption by Regions
-
Table China Chlamydia Infection Therapeutics Consumption Share by Regions
-
Figure China Chlamydia Infection Therapeutics Consumption Share by Regions in 2016
-
Figure China Chlamydia Infection Therapeutics Consumption Share by Regions in 2021
-
Figure China Chlamydia Infection Therapeutics Consumption Share by Regions in 2027
-
Table North China Chlamydia Infection Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Chlamydia Infection Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Chlamydia Infection Therapeutics Consumption Share by Types in 2016
-
Figure North China Chlamydia Infection Therapeutics Consumption Share by Types in 2021
-
Figure North China Chlamydia Infection Therapeutics Consumption Share by Types in 2027
-
Table North China Chlamydia Infection Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Chlamydia Infection Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Chlamydia Infection Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Chlamydia Infection Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Chlamydia Infection Therapeutics Consumption Share by Types in 2016
-
Figure Central China Chlamydia Infection Therapeutics Consumption Share by Types in 2021
-
Figure Central China Chlamydia Infection Therapeutics Consumption Share by Types in 2027
-
Table Central China Chlamydia Infection Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Chlamydia Infection Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2027
-
Table South China Chlamydia Infection Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Chlamydia Infection Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Chlamydia Infection Therapeutics Consumption Share by Types in 2016
-
Figure South China Chlamydia Infection Therapeutics Consumption Share by Types in 2021
-
Figure South China Chlamydia Infection Therapeutics Consumption Share by Types in 2027
-
Table South China Chlamydia Infection Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Chlamydia Infection Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2027
-
Table East China Chlamydia Infection Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Chlamydia Infection Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Chlamydia Infection Therapeutics Consumption Share by Types in 2016
-
Figure East China Chlamydia Infection Therapeutics Consumption Share by Types in 2021
-
Figure East China Chlamydia Infection Therapeutics Consumption Share by Types in 2027
-
Table East China Chlamydia Infection Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Chlamydia Infection Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Chlamydia Infection Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Chlamydia Infection Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Chlamydia Infection Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Chlamydia Infection Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Chlamydia Infection Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Chlamydia Infection Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Chlamydia Infection Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Chlamydia Infection Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Chlamydia Infection Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Chlamydia Infection Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Chlamydia Infection Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Chlamydia Infection Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Chlamydia Infection Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Chlamydia Infection Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Chlamydia Infection Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Chlamydia Infection Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Chlamydia Infection Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Chlamydia Infection Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Chlamydia Infection Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Chlamydia Infection Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Chlamydia Infection Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Chlamydia Infection Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of DiaSorin SpA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DiaSorin SpA
-
Figure Sales and Growth Rate Analysis of DiaSorin SpA
-
Figure Revenue and Market Share Analysis of DiaSorin SpA
-
Table Product and Service Introduction of DiaSorin SpA
-
Table Company Profile and Development Status of Bio Rad Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio Rad Laboratories
-
Figure Sales and Growth Rate Analysis of Bio Rad Laboratories
-
Figure Revenue and Market Share Analysis of Bio Rad Laboratories
-
Table Product and Service Introduction of Bio Rad Laboratories
-
Table Company Profile and Development Status of Thermo Fisher Scientific
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific
-
Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific
-
Figure Revenue and Market Share Analysis of Thermo Fisher Scientific
-
Table Product and Service Introduction of Thermo Fisher Scientific
-
Table Company Profile and Development Status of Danaher Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher Corporation
-
Figure Sales and Growth Rate Analysis of Danaher Corporation
-
Figure Revenue and Market Share Analysis of Danaher Corporation
-
Table Product and Service Introduction of Danaher Corporation
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Siemens AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens AG
-
Figure Sales and Growth Rate Analysis of Siemens AG
-
Figure Revenue and Market Share Analysis of Siemens AG
-
Table Product and Service Introduction of Siemens AG
-
Table Company Profile and Development Status of F Hoffmann-La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
-
Table Product and Service Introduction of F Hoffmann-La Roche
-
Table Company Profile and Development Status of BD Medical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD Medical
-
Figure Sales and Growth Rate Analysis of BD Medical
-
Figure Revenue and Market Share Analysis of BD Medical
-
Table Product and Service Introduction of BD Medical
-
Table Company Profile and Development Status of BioMerieux
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux
-
Figure Sales and Growth Rate Analysis of BioMerieux
-
Figure Revenue and Market Share Analysis of BioMerieux
-
Table Product and Service Introduction of BioMerieux
-

Chinese